{"id":66778,"url":"https://lda.senate.gov/api/v1/clients/66778/?format=json","client_id":66778,"name":"ULTRAGENYX PHARMACEUTICAL","general_description":"Biopharma company","client_government_entity":null,"client_self_select":false,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-05-02","registrant":{"id":401109532,"url":"https://lda.senate.gov/api/v1/registrants/401109532/?format=json","house_registrant_id":77012,"name":"AVIVA STRATEGIES (FKA MGB CONSULTING)","description":null,"address_1":"2724 12th Street Northeast, Unit 15","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20018","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAX GABRIEL BRONSTEIN","contact_telephone":"+1 703-244-3380","dt_updated":"2026-07-17T10:49:31.549297-04:00"}}